Bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model.

Source:http://linkedlifedata.com/resource/pubmed/id/16166319

Cancer Res. 2005 Sep 15 65 18 8406-13

Download in:

View as

Triples

General Info

PMID
16166319